Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Boehringer to target COPD adherence

Partners with Propeller Health on digital health deal
Boehringer Ingelheim

Boehringer Ingelheim has signed a new digital health deal that it hopes will help with aimed adherence and care management for people living with COPD and asthma.

The firm says its US deal with Propeller Health is the first commercial partnership of its kind in respiratory medicine.

The deal will see people living with COPD and asthma and treated with a Boehringer medication that can be used in its Respimat inhaler offered the opportunity to enrol - via select US health systems - in a new programme.

This is designed to determine how Propeller's novel health technology tool for the Respimat inhaler impacts adherence rates and patient engagement.

Propeller uses a combination of inhaler sensors, apps, analytics, personal feedback and education to passively track how patients use inhaled medications.

Ruchin Kansal, executive director and head, business innovation at Boehringer Ingelheim Pharmaceuticals, said: “Boehringer Ingelheim is proud to embark on this industry-leading partnership with Propeller with the goal of improving the care of people living with COPD and asthma.”

11th April 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics